Mativ's 2024 Results: A Year of Operational Excellence and Strategic Growth

Mativ Holdings, Inc. (NYSE: MATV) has announced its conference call to discuss the fourth quarter and full year 2024 results, scheduled for February 21, 2025, after the market closes. The call, which can be accessed via webcast or by telephone, will provide investors with insights into the company's financial performance and strategic initiatives for the year ahead. As Mativ continues to execute on its growth strategy, investors are eager to learn more about the company's progress in key areas such as healthcare, optical films, and release liners.

Mativ's strategic focus on operational improvements and growth in key areas has significantly contributed to its financial performance in 2024. The company has made notable investments in these areas, including a new medical films line in the U.K., aiming for a Q1 2025 start, and a new line for specialty tapes in Canada, projected to generate over $20 million in additional revenue by the third year of operation after its early 2026 startup. These investments have helped Mativ to improve its manufacturing processes, optimize costs, and increase its market share in these key areas. As a result, Mativ has seen meaningful increases in volume and profitability in its Filtration and overall SAS segment during the third quarter of 2024, with SAS segment adjusted EBITDA increasing almost 20% year over year.



Mativ's expansion into new markets, such as smart glass in partnership with Miru, has also contributed to its revenue growth and is expected to bring significant benefits in the coming years. The company expects to generate over $115 million in additional revenue over the next 3-4 years from investments announced in 2023 and 2024, including the smart glass partnership with Miru. This expansion into innovative products like smart glass, which targets increased energy efficiency and aesthetic improvements, is a strategic move to diversify Mativ's revenue streams and tap into new market opportunities. By leveraging its expertise in materials science and partnering with innovative companies like Miru, Mativ is well-positioned to capitalize on emerging trends and technologies in various industries.

Mativ's turnaround efforts for underperforming categories, particularly advanced films, have also had a positive impact on the company's overall performance. The company has assembled a dedicated 'tiger team' to focus on turning around the advanced films segment, investing in cost-efficient materials, and optimizing manufacturing processes. These initiatives have led to a 10% increase in adjusted EBITDA compared to the prior year, driven by improved manufacturing performance, lower SG&A and distribution expenses, and increased volumes in the Filtration and SAS segments. Despite challenges in the advanced films segment, Mativ's overall adjusted EBITDA margin increased by 110 basis points compared to the prior year.

As Mativ continues to execute on its growth strategy, investors are looking forward to the company's fourth quarter and full year 2024 results. The conference call will provide valuable insights into the company's financial performance and strategic initiatives for the year ahead, as Mativ continues to focus on operational improvements, growth in key areas, and expansion into new markets. With a strong track record of execution and a commitment to driving long-term value for shareholders, Mativ is well-positioned to continue its growth trajectory in 2025 and beyond.